---
title: "Jiuzhitang Co.,Ltd. (000989.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000989.SZ.md"
symbol: "000989.SZ"
name: "Jiuzhitang Co.,Ltd."
industry: "Pharmaceuticals"
datetime: "2026-05-20T22:34:04.383Z"
locales:
  - [en](https://longbridge.com/en/quote/000989.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000989.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000989.SZ.md)
---

# Jiuzhitang Co.,Ltd. (000989.SZ)

## Company Overview

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong capsules for gynecological treatment; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription drug product systems, Jiaxi Ganxian granules, and Chidan Tuihuang granules for liver diseases. The company also provides over-the-counter (OTC) drugs comprising blood-tonifying, cardiovascular and cerebrovascular, urinary system, pediatric, gynecologic, bone and muscles, respiratory system, dermatologic, nervous system, ENT, and digestive system products, and stem cell and other drugs.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.hnjzt.com](https://www.hnjzt.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: B (0.33)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 37 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 14.27% |  |
| Net Profit YoY | 44.04% |  |
| P/B Ratio | 1.92 |  |
| Dividend Ratio | 3.42% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 7434217048.33 |  |
| Revenue | 2401082455.56 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 7.01% | C |
| Profit Margin | 11.31% | B |
| Gross Margin | 60.59% | A |
| Revenue YoY | 14.27% | B |
| Net Profit YoY | 44.04% | B |
| Total Assets YoY | 6.38% | B |
| Net Assets YoY | 5.50% | C |
| Cash Flow Margin | 179.14% | B |
| OCF YoY | 14.27% | B |
| Turnover | 0.43 | C |
| Gearing Ratio | 25.09% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Jiuzhitang Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "14.27%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "44.04%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.92",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "3.42%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "7434217048.33",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2401082455.56",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "7.01%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "11.31%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "60.59%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "14.27%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "44.04%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "6.38%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "5.50%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "179.14%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "14.27%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.43",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "25.09%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 27.00 | 66/215 | 60.99 | 56.18 | 40.67 |
| PB | 1.89 | 77/215 | 2.44 | 2.18 | 2.07 |
| PS (TTM) | 3.05 | 77/215 | 4.54 | 4.02 | 3.69 |
| Dividend Yield | 3.47% | 26/215 | 3.32% | 3.11% | 2.82% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/000989.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/000989.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/000989.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/000989.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**